Cargando…
Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
Cancer remains an obstacle to be surmounted by humans. As an FDA-approved biocompatible drug excipient, d-α-tocopheryl polyethylene glycol succinate (TPGS) has been widely applied in drug delivery system (DDS). Along with in-depth analyses of TPGS-based DDS, increasingly attractive results have reve...
Autores principales: | Tan, Songwei, Zou, Chenming, Zhang, Wei, Yin, Mingxing, Gao, Xueqin, Tang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241040/ https://www.ncbi.nlm.nih.gov/pubmed/29182031 http://dx.doi.org/10.1080/10717544.2017.1406561 |
Ejemplares similares
-
Correction to: Tan et al., Recent developments in D-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
Publicado: (2017) -
Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases
por: Srivastava, Ajay, et al.
Publicado: (2019) -
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions
por: Sun, Deqing, et al.
Publicado: (2014) -
Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate
por: Ren, Tianming, et al.
Publicado: (2022) -
Synthesis, Colloidal Characterization and Targetability of Phenylboronic Acid Functionalized α-Tocopheryl Polyethylene Glycol Succinate in Cancer Cells
por: Tiwari, Sanjay, et al.
Publicado: (2020)